ME/CFS AUSTRALIA (SA) INC
Registered Charity 698
PO Box 28,
South Australia 5007
Closed while relocating
1300 128 339
ME/CFS Australia (SA) Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.
ME/CFS Australia (SA) Inc aims to keep members informed of the various research projects, diets, medications, therapies etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.
Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.
Sodium Oxybate for Fibromyalgia
Sunday 19 July 2009
Sodium oxybate is the active ingredient in the narcolepsy drug Xyrem. It's already widely used, off label, as a fibromyalgia treatment. It's a controlled substance, however, and requires close monitoring by your doctor.
Jazz says side effects were mild to moderate and included headache, nausea, dizziness, vomiting, diarrhea, anxiety and sinusitis.
The company has completed a second Phase III trial and expects to announce results within the next few months. If results continue to be positive, Jazz expects to file a New Drug Application with the FDA by the end of 2009. If approved, the drug could conceivably come on the market sometime in 2010 or 2011.
• Learn More About JZP-6 Sodium Oxybate
This article originally appeared here.
blog comments powered by Disqus